What's the protocol for loading and maintaining vitamin D?

How it works

Vitamin D from supplementation is converted to 25-hydroxyvitamin D in the liver and stored in body tissues. Severely depleted stores cannot be restored quickly with maintenance doses alone (typically 8-16 weeks at 4,000 IU daily); loading regimens compress this to 6-10 weeks. Once stores are repleted, a maintenance dose of 800-2,000 IU daily generally sustains adequate serum 25(OH)D in adults without ongoing high-dose intake.

Effective dose

Holick 2011 (PMID 21646368) is the canonical international source for the 50,000 IU weekly for 8 weeks regimen; the 2011 Endocrine Society target was 25(OH)D above 75 nmol/L. The 2024 Endocrine Society guideline (Demay PMID 38828931) explicitly states that specific 25(OH)D thresholds for adequacy cannot be reliably set from current evidence and recommends against routine testing in healthy adults; this is a notable shift from 2011. UK PHE classification: deficiency below 25 nmol/L; insufficiency 25-50 nmol/L; sufficiency 50 nmol/L and above. Targets above 75 nmol/L are not mainstream UK NHS practice; immune-optimisation targets of 100-125 nmol/L are not endorsed by major guideline bodies.

Forms compared

Other formulations (sublingual, oily liquid, topical) have weaker evidence than standard oral D3 capsules and are not part of NHS prescribing practice. Loading regimens use standard oral D3 capsules at higher unit strengths or higher frequency; the underlying molecule and absorption pathway are the same as maintenance.

Timing

Daily, weekly, and short-burst regimens all achieve repletion at similar 12-week endpoints when delivering equivalent total doses. Daily-only protocols at maintenance dose (800-2,000 IU) without a loading phase typically take 8-16 weeks to reach steady-state and may not be appropriate for symptomatic severe deficiency where faster repletion is clinically indicated.

Safety profile

Avoid loading without confirmed deficiency on serum 25(OH)D testing. Routine repeat-loading is not standard NHS practice; once repletion is confirmed, transition to maintenance and monitor only if symptoms recur or risk factors change. Granulomatous diseases (sarcoidosis, tuberculosis), primary hyperparathyroidism, and metastatic disease can produce inappropriate 1,25-dihydroxyvitamin D conversion; loading is contraindicated without specialist input in these contexts.

Special populations

Vegetarians and vegans: standard D3 oral preparations are typically lanolin-derived; lichen-derived D3 and D2 alternatives are available. Children: paediatric loading regimens are weight-based and managed under specialist or primary care guidance per NICE and BNF for Children. Granulomatous diseases: avoid loading without specialist input due to risk of inappropriate active vitamin D production.

Interactions

K2 considerations are covered in entries dde5d38f and 457ce028. Calcium supplementation alongside vitamin D should be reviewed in patients with cardiovascular risk and in chronic kidney disease, where the calcium-vitamin D balance has specific clinical considerations under specialist input.

Guideline positions

The 2024 Endocrine Society update is the most significant shift in the field: it explicitly does not endorse specific 25(OH)D adequacy thresholds beyond avoiding deficiency, and it recommends against routine testing in healthy adults. UK NHS practice continues to use the PHE classification (under 25 nmol/L deficient; 25-50 insufficient; above 50 sufficient). Loading regimens follow local NHS prescribing protocols; the BNSSG guidance is one widely-referenced UK example.

Practical framework

Self-administered loading without serum 25(OH)D confirmation is not recommended. Maintenance above 4,000 IU/day chronically is not supported by mainstream guidelines for non-deficient adults. Adjust loading magnitude upward in obesity, malabsorption, and anticonvulsant or glucocorticoid use under clinical assessment. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: applying adult loading regimens in pregnancy without specialist guidance; UK obstetric practice favours lower-dose protocols (20,000 IU weekly for 4-6 weeks per BNSSG NHS guidance) followed by standard supplementation.

Claim: continuing maintenance above 4,000 IU/day without indication; this exceeds the NHS UL and the Burt 2019 signal of bone-density loss applies.